Sector consensus IXICO plc

Equities

Delayed London S.E. Other stock markets 03:04:42 2026-05-19 EDT			5-day change	1st Jan Change
7.475 ^GBX	+10.74%		+10.74%	-36.38%

02:41am	Ixico remains focused on delivering on guidance of 15% revenue growth for full year	RE
02:02am	Earnings Flash (IXI.L) Ixico plc Reports Fiscal H1 Revenue GBP3.9M	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
IXICO PLC	-	-	0.26	+285.19%	1
LONZA GROUP AG			667.61	+42.56%	23
BEONE MEDICINES AG			411.38	+40.36%	27
REVOLUTION MEDICINES, INC.			184.45	+27.76%	20
IQVIA HOLDINGS INC.			228.6	+32.28%	20
CELLTRION, INC.			262,833.33	+43.47%	24
IONIS PHARMACEUTICALS, INC.			100.78	+38.97%	23
EUROFINS SCIENTIFIC SE			71.1	+18.34%	14
MEDPACE HOLDINGS, INC.			442.83	+5.27%	12
PRAXIS PRECISION MEDICINES, INC.			652.18	+103.47%	17
ABIVAX			121.48	+27.07%	7
ICON PUBLIC LIMITED COMPANY			132.6	+16.54%	15
TEMPUS AI, INC.			67.2	+54.06%	15
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			208.8	+39.26%	15
BACHEM HOLDING AG			78.8	+3.14%	10
QIAGEN N.V.			43.82	+29.72%	14
BIO-TECHNE CORPORATION			61.42	+38.23%	12
KYMERA THERAPEUTICS, INC.			118.27	+48.45%	22
Average			14,801.38	+49.68%	16
Weighted average by Cap.			25,717.67	+36.13%	20